Inosine

Inosine

SCHEMBL311515

NP(=O)(O)O.OC[C@H]1O[C@@H](n2cnc3c(O)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.68
▸ SMN1; SMN2 Q16637 3/20 0.68
▸ SLC29A1 Q99808 2/20 0.68
▸ DPP4 P27487 1/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ SLC28A1 O00337 1/20 0.68
▸ MAP3K7 O43318 1/20 0.68
▸ SLC28A2 O43868 1/20 0.68
▸ GAPDH P04406 1/20 0.68
▸ ADORA3 P0DMS8 1/20 0.68
▸ MAPK1 P28482 1/20 0.68
▸ ADORA2A P29274 1/20 0.68
▸ ADORA2B P29275 1/20 0.68
▸ STAT6 P42226 1/20 0.68
▸ PI4KA P42356 1/20 0.68
▸ KMT2A Q03164 1/20 0.68
▸ PI4K2B Q8TCG2 1/20 0.68
▸ DOT1L Q8TEK3 1/20 0.68
▸ PI4K2A Q9BTU6 1/20 0.68
▸ SLC28A3 Q9HAS3 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Inosine SCHEMBL28371780 0.97 ADORA3 (0.69) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL29898199 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL29941344 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL27486904 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL5365023 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL17824478 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL161317 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL1331735 0.95 SLC29A1 (0.67) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL19436352 0.94 ADORA1 (0.66) ADORA1SMN1; SMN2SLC29A1DPP4MEN1
Inosine SCHEMBL10622941 0.94 SLC29A1 (0.66) ADORA1SMN1; SMN2SLC29A1DPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4293127-A2 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY Seegene, Inc. (KR) 2023-12-20 — — EP claimed
EP-4001428-B1 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY SEEGENE INC (KR) 2023-11-22 — — EP claimed
CN-110168103-B Methods for reducing primer dimer formation and increasing amplification efficiency SEEGENE株式会社 2023-09-08 — — CN claimed
CN-115341017-A Kit and detection method for rapidly detecting gene variation based on lighted click connection probe 中国人民解放军陆军特色医学中心 2022-11-15 — — CN claimed
EP-4001428-A1 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY Seegene, Inc. (KR) 2022-05-25 — — EP claimed
EP-3562958-B1 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY SEEGENE INC (KR) 2021-11-03 — — EP claimed
US-10870675-B2 Process using dual specificity oligonucleotide and dual specificity oligonucleotide SEEGENE, INC. (KR) 2020-12-22 — — US claimed
EP-3562958-A1 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY Seegene, Inc. (KR) 2019-11-06 — — EP claimed
US-20190316193-A1 METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY SEEGENE, INC. (KR) 2019-10-17 — — US claimed
CN-110168103-A Reduce the method that primer dimer forms and improves amplification efficiency SEEGENE株式会社 2019-08-23 — — CN claimed
WO-2005083120-A1 METHOD FOR AMPLIFYING MEMBERS OF A GENE FAMILY SEEGENE, INC. (KR) 2005-09-09 — — WO claimed
WO-2005083121-A1 METHOD FOR AMPLIFYING MEMBERS OF A GENE FAMILY SEEGENE, INC. (KR) 2005-09-09 — — WO claimed
US-20050164184-A1 Hybridization portion control oligonucleotide and its uses SEEGENE, INC. (KR) 2005-07-28 — — US claimed
WO-2005045073-A1 METHOD FOR AMPLIFYING UNKNOWN DNA SEQUENCE ADJACENT TO KNOWN SEQUENCE SEEGENE, INC. (KR) 2005-05-19 — — WO claimed
CN-1602361-A Hybridization portion control oligonucleotide and use thereof SEEGENE INC (KR) 2005-03-30 — — CN claimed
EP-1448795-A1 HYBRIDIZATION PORTION CONTROL OLIGONUCLEOTIDE AND ITS USES Seegene, Inc. (KR) 2004-08-25 — — EP claimed
EP-1448793-A1 ANNEALING CONTROL PRIMER AND ITS USES Seegene, Inc. (KR) 2004-08-25 — — EP claimed
US-20030175749-A1 Annealing control primer and its uses SEEGENE, INC. (KR) 2003-09-18 — — US claimed
WO-2003050306-A1 HYBRIDIZATION PORTION CONTROL OLIGONUCLEOTIDE AND ITS USES SEEGENE, INC. (KR) 2003-06-19 — — WO claimed
WO-2003050305-A1 ANNEALING CONTROL PRIMER AND ITS USES SEEGENE, INC. (KR) 2003-06-19 — — WO claimed
Send feedback